Selma Atalay - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Selma Atalay

This paper was not found in any repository, but could be made available legally by the author.

2022 Lara S. van der Schoot

ORCID

, Selma Atalay

ORCID

, Marisol E. Otero

ORCID

, Wietske Kievit

ORCID

, Juul M. P. A. van den Reek

ORCID

, Elke M. G. J. de Jong

ORCID

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab

Upload

This paper is made freely available by the publisher.

2021 Marloes E. van Muijen

ORCID

, S. Atalay

ORCID

, L. J. van Vugt

ORCID

, L. M. D. Vandermaesen

ORCID

, J. M. P. A. van den Reek

ORCID

, E. M. G. J. de Jong

ORCID

Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 S. Atalay

ORCID

, Jmpa M. P. A. van den Reek

ORCID

, Jmm M. M. Groenewoud

ORCID

, Pcm C. M. van de Kerkhof

ORCID

ORCID

, Emgj M. G. J. de Jong

ORCID

Two-year Follow-up of a Dose Reduction Strategy Trial of Biologics Adalimumab, Etanercept, and Ustekinumab in Psoriasis Patients in Daily Practice

Upload

This paper is made freely available by the publisher.

2017 Selma Atalay

ORCID

, Juul M. P. A. van den Reek, Lieke J. van Vugt, Marisol E. Otero, Peter C. M. van de Kerkhof, Alfons A. den Broeder, Wietske Kievit, Elke M. G. J. de Jong

Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial

Download from doi.org

Missing publications? Search for publications with a matching author name.